PMC Articles for PubChem Compound (Select 3899) - PMC

Result Filters

Links from PubChem Compound

Items: 1 to 20 of 711

<< First< Prev

Page of 36

Next >Last >>

Select item 110112601.

Leflunomide Treatment Does Not Protect Neural Cells following Oxygen-Glucose Deprivation (OGD) In Vitro

Claire J. M. Curel, Irene Nobeli, Claire Thornton

Cells. 2024 Apr; 13(7): 631. Published online 2024 Apr 4. doi: 10.3390/cells13070631

PMCID:: PMC11011260

Article PDF–2.7M

Select item 109615472.

Medication utilisation trends during pregnancy and factors influencing adverse pregnancy outcomes in patients with rheumatoid arthritis

Yeo-Jin Song, Soo-Kyung Cho, Yu-Seon Jung, Sun-Young Jung, Jihyun Keum, Eunwoo Nam, Yoon-Kyoung Sung, Dae Hyun Yoo

RMD Open. 2024; 10(1): e003739. Published online 2024 Mar 22. doi: 10.1136/rmdopen-2023-003739

PMCID:: PMC10961547

Article PDF–832K

Select item 109266453.

Efficacy and safety of low-dose corticosteroids combined with leflunomide for progressive IgA nephropathy: a systematic review and meta-analysis

Dongxu Zhang, Bowen Xia, Xin Zhang, Pu Liang, Xiaopeng Hu

BMC Urol. 2024; 24: 56. Published online 2024 Mar 11. doi: 10.1186/s12894-024-01438-3

PMCID:: PMC10926645

Article PDF–2.9M

Select item 108305814.

Leflunomide-induced collagenous colitis: a case report and literature review

Jamie O. Yang, Sarah Dry, Guy A. Weiss

Clin J Gastroenterol. 2024; 17(1): 65–68. Published online 2023 Oct 5. doi: 10.1007/s12328-023-01862-2

PMCID:: PMC10830581

Article PDF–603K

Select item 107145635.

Retrospective evaluation of prognosis and survival with various immunosuppressants in 82 dogs diagnosed with meningoencephalitis of unknown etiology (2010–2021)

So-Hee Kim, Ye-In Oh, Su-Min Park, Ju Hyun An, Tae-Hee Kim, Sung-Soo Kim, Jae-Gon Ah, Kyoung-Won Seo, Hwa-Young Youn

BMC Vet Res. 2023; 19: 269. Published online 2023 Dec 12. doi: 10.1186/s12917-023-03800-3

PMCID:: PMC10714563

Article PDF–1.3M

Select item 105134886.

The prognostic value of whole-genome DNA methylation in response to Leflunomide in patients with Rheumatoid Arthritis

Yulan Chen, Qiao Wang, Haina Liu, Lei Jin, Xin Feng, Bingbing Dai, Meng Chen, Fangran Xin, Tingting Wei, Bingqing Bai, Zhijun Fan, Jiahui Li, Yuxin Yao, Ruobing Liao, Jintao Zhang, Xiangnan Jin, Lingyu Fu

Front Immunol. 2023; 14: 1173187. Published online 2023 Sep 7. doi: 10.3389/fimmu.2023.1173187

PMCID:: PMC10513488

Article PDF–6.3M

Select item 104561417.

Comparative analysis of multiorgan toxicity induced by long term use of disease modifying anti-rheumatic drugs

Tamseela Mumtaz, Ayesha Tahir, Maham Almas Tariq, Muhammad Amir Iqbal

PLoS One. 2023; 18(8): e0290668. Published online 2023 Aug 25. doi: 10.1371/journal.pone.0290668

PMCID:: PMC10456141

Article PDF–1.2M

Select item 104411868.

Biologic Agents in Rheumatoid Arthritis: An Update for Managed Care Professionals

Sandeep K. Agarwal

J Manag Care Pharm. 2011 Nov; 17(9 Suppl B): 10.18553/jmcp.2011.17.s9-b.S14. doi: 10.18553/jmcp.2011.17.s9-b.S14

PMCID:: PMC10441186

Abstract PDF–378K

Select item 104380989.

Frequency, Predictors, and Economic Impact of Upward Dose Adjustment of Infliximab in Managed Care Patients With Rheumatoid Arthritis

Daniel A. Ollendorf, Elena Massarotti, Charles Birbara, Somali Misra Burgess

J Manag Care Pharm. 2005 May; 11(5): 10.18553/jmcp.2005.11.5.383. doi: 10.18553/jmcp.2005.11.5.383

PMCID:: PMC10438098

Abstract PDF–268K

Select item 1043750210.

Review of Eight Pharmacoeconomic Studies of the Value of Biologic DMARDs Adalimumab, Etanercept, and Infliximab) in the Management of Rheumatoid Arthritis

Quan V. Doan, Chiun-Fang Chiou, Robert W. Dubois

J Manag Care Pharm. 2006 Sep; 12(7): 10.18553/jmcp.2006.12.7.555. doi: 10.18553/jmcp.2006.12.7.555

PMCID:: PMC10437502

Abstract PDF–329K

Select item 1040126111.

Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren’s syndrome that show potential to predict and monitor clinical response

Safae Hamkour, Eefje HM van der Heijden, Ana P Lopes, Sofie L M Blokland, Cornelis P J Bekker, Cornelia G Van Helden-Meeuwsen, Marjan A Versnel, Aike A Kruize, Timothy RDJ Radstake, Helen L Leavis, Maarten R Hillen, Joel AG van Roon

RMD Open. 2023; 9(3): e002979. Published online 2023 Aug 2. doi: 10.1136/rmdopen-2023-002979

PMCID:: PMC10401261

Article PDF–1.4M

Select item 1039569012.

Outcome of solid and cavitary pulmonary nodules in rheumatoid arthritis patients—case series

Aysun AKSOY, Derya KOCAKAYA, Yasemin YALÇINKAYA, Emine BOZKURTLAR, Sait KARAKURT, Emel ERYÜKSEL, Nevsun İNANÇ

Turk J Med Sci. 2022; 52(5): 1713–1720. Published online 2022 Apr 19. doi: 10.55730/1300-0144.5514

PMCID:: PMC10395690

Article PDF–289K

Select item 1022617713.

Anti-inflammatory Effects of First-line Anti-arthritic Drugs on T-cell Activation

Nicholas Manolios, Guojiang Hou

Antiinflamm Antiallergy Agents Med Chem. 2022 Mar 3; 21(3): 188–193. Published online 2022 Mar 3. doi: 10.2174/1871523022666230201144553

PMCID:: PMC10226177

Article PDF–2.3M

Select item 1017928814.

Mitochondrial Quality Control and Metabolic Memory Phenomenon Associated with Continued Progression of Diabetic Retinopathy

Renu A. Kowluru, Kumari Alka

Int J Mol Sci. 2023 May; 24(9): 8076. Published online 2023 Apr 29. doi: 10.3390/ijms24098076

PMCID:: PMC10179288

Article PDF–4.2M

Select item 1013145815.

Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report

Ke Xu, Mengjie Zhang, Shilin Yang, Gang Yu, Peng Zheng, Xinyue Qin, Jinzhou Feng

BMC Neurol. 2023; 23: 168. Published online 2023 Apr 26. doi: 10.1186/s12883-023-03146-1

PMCID:: PMC10131458

Article PDF–1.3M

Select item 1010591716.

Leflunomide treatment for patients hospitalised with COVID-19: DEFEAT-COVID randomised controlled trial

Ines Kralj-Hans, Kuo Li, Adrian Wesek, Alexia Lamorgese, Fatima Omar, Kapila Ranasinghe, Megan McGee, Kieran Brack, Shiliang Li, Ritesh Aggarwal, Ajay Bulle, Aparna Kodre, Shashank Sharma, David Fluck, Isaac John, Pankaj Sharma, Jonathan D Belsey, Ling Li, Sreenivasa Rao Kondapally Seshasai, Hong Lin Li, Nandor Marczin, Zhong Chen, DEFEAT-COVID Investigators

BMJ Open. 2023; 13(4): e068179. Published online 2023 Apr 13. doi: 10.1136/bmjopen-2022-068179

PMCID:: PMC10105917

Article PDF–1.3M

Select item 1006528817.

Treatment of refractory lupus nephritis using leflunomide: A prospective study

Shuo Zhang, Yiran Chen, Xin Chen, Yan Zhao, Xiaofeng Zeng, Fengchun Zhang, Li Wang, Mengtao Li

Front Immunol. 2023; 14: 1133183. Published online 2023 Mar 17. doi: 10.3389/fimmu.2023.1133183

PMCID:: PMC10065288

Article PDF–728K

Select item 997277718.

Interventions for preventing and treating kidney disease in IgA vasculitis

Cochrane Database Syst Rev. 2023; 2023(2): CD005128. Published online 2023 Feb 28. doi: 10.1002/14651858.CD005128.pub4

PMCID:: PMC9972777

Article PDF–904K

Select item 989833419.

Leflunomide abrogates neuroinflammatory changes in a rat model of Alzheimer’s disease: the role of TNF-α/NF-κB/IL-1β axis inhibition

Menna Nafea, Mona Elharoun, Mohammad Mohmoud Abd-Alhaseeb, Maged Wasfy Helmy

Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(3): 485–498. Published online 2022 Nov 17. doi: 10.1007/s00210-022-02322-3

PMCID:: PMC9898334

Article PDF–2.6M

Select item 987858520.

Efficacy of leflunomide in the treatment of vasculitis

N. Mustapha, L. Barra, S. Carette, D. Cuthbertson, N.A. Khalidi, C.L. Koening, C.A. Langford, C.A. McAlear, N. Milman, L.W. Moreland, P.A. Monach, P. Seo, U. Specks, A.G. Sreih, S.Y. Ytterberg, P.A. Merkel, C. Pagnoux

Clin Exp Rheumatol. Author manuscript; available in PMC 2023 Jan 26.

Published in final edited form as: Clin Exp Rheumatol. 2021 Mar-Apr; 39(Suppl 129): 114–118. Published online 2020 Nov 10. doi: 10.55563/clinexprheumatol/ve38dj